COCHLEAR LTD ADR 1/2/O.N. (F:OC50) — Market Cap & Net Worth

$4.65 Billion USD · €3.98 Billion EUR · Rank #3766

Market Cap & Net Worth: COCHLEAR LTD ADR 1/2/O.N. (OC50)

COCHLEAR LTD ADR 1/2/O.N. (F:OC50) has a market capitalization of $4.65 Billion (€3.98 Billion) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #3766 globally and #673 in its home market, demonstrating a -42.10% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying COCHLEAR LTD ADR 1/2/O.N.'s stock price €30.40 by its total outstanding shares 130797362 (130.80 Million).

COCHLEAR LTD ADR 1/2/O.N. Market Cap History: 2021 to 2026

COCHLEAR LTD ADR 1/2/O.N.'s market capitalization history from 2021 to 2026. Data shows change from $9.97 Billion to $4.13 Billion (-12.24% CAGR).

COCHLEAR LTD ADR 1/2/O.N. Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how COCHLEAR LTD ADR 1/2/O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of OC50 by Market Capitalization

Companies near COCHLEAR LTD ADR 1/2/O.N. in the global market cap rankings as of May 2, 2026.

Key companies related to COCHLEAR LTD ADR 1/2/O.N. by market ranking:

Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#141	Abbott Laboratories	NYSE:ABT	$155.56 Billion	$89.46
#208	Stryker Corporation	NYSE:SYK	$112.79 Billion	$294.73
#230	Medtronic plc	SA:MDTC34	$104.84 Billion	R$208.39
#236	Medtronic PLC	NYSE:MDT	$102.56 Billion	$80.00

COCHLEAR LTD ADR 1/2/O.N. Historical Marketcap From 2021 to 2026

Between 2021 and today, COCHLEAR LTD ADR 1/2/O.N.'s market cap moved from $9.97 Billion to $ 4.13 Billion, with a yearly change of -12.24%.

Year	Market Cap	Change (%)
2026	€4.13 Billion	-63.51%
2025	€11.32 Billion	-14.45%
2024	€13.23 Billion	-4.58%
2023	€13.86 Billion	+46.97%
2022	€9.43 Billion	-5.35%
2021	€9.97 Billion	--

End of Day Market Cap According to Different Sources

On Apr 24th, 2026 the market cap of COCHLEAR LTD ADR 1/2/O.N. was reported to be:

Source	Market Cap
Yahoo Finance	$4.65 Billion USD
MoneyControl	$4.65 Billion USD
MarketWatch	$4.65 Billion USD
marketcap.company	$4.65 Billion USD
Reuters	$4.65 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About COCHLEAR LTD ADR 1/2/O.N.

F:OC50 Germany Medical Devices

Market Cap

$4.65 Billion

€3.98 Billion EUR

Market Cap Rank

#3766 Global

#673 in Germany

Share Price

€30.40

Change (1 day)

-38.71%

52-Week Range

€30.40 - €89.50

All Time High

€104.15